▷ Malin Corporation Dividends 【Calendar 2026】

Upcoming Malin Corporation dividend

Change(%)

0.00%

No change

Next payment N/A

Next payment date N/A

Last payment N/A

Last payment date N/A

00 D 00 H 00 M 00 S

Ex-Dividend: N/A

Not available

When are the upcoming Malin Corporation dividends in 2026?

▶

Regarding 2026, Malin Corporation has not yet made any announcements related to dividend distribution.

Dividend policy of Malin Corporation

▶

Malin Corporation PLC, listed on the main market in Ireland and in the United States, using the ticker symbol MLC, has not paid any dividends to its shareholders to date.

Payout Ratio Malin Corporation Dividends

In the last fiscal period, Malin Corporation paid no dividends, resulting in a dividend payout ratio of 0%.

Malin Corporation has not distributed dividends in the last fiscal period, therefore, the payout ratio is 0%.

Dividend payout ratio Payout Ratio

Dividend calendar of Malin Corporation

There is no Dividend Calendar of Malin Corporation defined for 2026.

Information about Malin Corporation

Full name Malin Corporation plc

Ticker MLC

Sector Health Care

Industry Drug Manufacturers - Specialty & Generic

Market Capitalization 32.01 €

ISIN IE00BVGC3741

Number of Employees 5

Description of the company

Malin Corporation PLC, a corporation based in Ireland, is dedicated to investing in and supporting other life sciences companies, primarily those that are highly innovative and offer transformative results for patients with various pathologies and diseases.

The company's assets have extensive technology, specialized in the area of immunology, treatment for genetic diseases and oncology, so the group invests totally or partially in other associations, according to their results, such as:

Poseida Therapeutics, a clinical-stage biopharmaceutical company with a portfolio of T-cell products, creates drugs for the treatment of hematological malignancies such as tumors, prostate cancer and multiple myeloma.
Viamet, in which Malin invests in the treatment of recurrent vulvovaginal candidiasis, through VIVJOA.
Xenex is a company dedicated to the manufacture of medical devices associated with disinfection in health care centers by means of LightStrike TM Germ-Zapping TM robots, eliminating fungi, bacteria and viruses.
CG Oncology, focused on oncology immunotherapy, focused on developing therapeutics for bladder cancer patients.
Wren, who hails from Cambridge University and Lund University, develops drugs to treat Alzheimer's and Parkinson's disease, as well as therapies for other diagnoses related to metabolic diseases, ophthalmology and neurology.
KNOW Bio, with an extensive catalog to meet many indications.
Artizan, with a platform dedicated to the elimination of bacteria concentrated in the intestine.